Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
162.17
+2.63 (1.65%)
At close: Jun 15, 2026, 4:00 PM EDT
162.45
+0.28 (0.17%)
After-hours: Jun 15, 2026, 7:58 PM EDT
Veeva Systems Revenue
Veeva Systems had revenue of $882.95M in the quarter ending April 30, 2026, with 16.32% growth. This brings the company's revenue in the last twelve months to $3.32B, up 16.25% year-over-year. In the fiscal year ending January 31, 2026, Veeva Systems had annual revenue of $3.20B with 16.34% growth.
Revenue (ttm)
$3.32B
Revenue Growth
+16.25%
P/S Ratio
7.94
Revenue / Employee
$418,670
Employees
7,928
Market Cap
26.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | 3.20B | 448.69M | 16.34% |
| Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
| Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
| Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
| Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
| Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
| Jan 31, 2020 | 1.10B | 241.87M | 28.05% |
| Jan 31, 2019 | 862.21M | 171.65M | 24.86% |
| Jan 31, 2018 | 690.56M | 146.52M | 26.93% |
| Jan 31, 2017 | 544.04M | 134.82M | 32.95% |
| Jan 31, 2016 | 409.22M | 96.00M | 30.65% |
| Jan 31, 2015 | 313.22M | 103.07M | 49.05% |
| Jan 31, 2014 | 210.15M | 80.60M | 62.22% |
| Jan 31, 2013 | 129.55M | 68.29M | 111.47% |
| Jan 31, 2012 | 61.26M | 32.13M | 110.31% |
| Jan 31, 2011 | 29.13M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 13.65B |
| Teladoc Health | 2.51B |
| Privia Health Group | 2.25B |
| Tempus AI | 1.36B |
| HealthEquity | 1.34B |
| Omnicell | 1.23B |
| Waystar Holding | 1.16B |
| Hinge Health | 646.34M |
VEEV News
- 6 days ago - UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite - PRNewsWire
- 11 days ago - Veeva price target lowered to $270 from $295 at Mizuho - TheFly
- 11 days ago - Morgan Stanley has ‘constructive bias’ on Veeva at current levels - TheFly
- 11 days ago - Veeva price target lowered to $235 from $300 at TD Cowen - TheFly
- 11 days ago - Veeva price target lowered to $185 from $240 at Evercore ISI - TheFly
- 11 days ago - Veeva price target lowered to $190 from $220 at UBS - TheFly
- 11 days ago - Veeva price target lowered to $175 from $220 at BMO Capital - TheFly
- 11 days ago - Veeva price target lowered to $230 from $245 at Stifel - TheFly